Earnings Call · Q1 FY2025·2025-05-15

Q1 25EPS +11.11%·Rev n/aQ4 24EPS +10.71%·Rev n/aQ3 24EPS 0.00%·Rev n/aQ2 24EPS -18.52%·Rev n/a⚠ consensus missing

Gossamer Bio, Inc. GOSS

Bryan Giraudo — Chief Financial Officer and Chief Operating Officer

Faheem Hasnain — Founder, Chairman, and Chief Executive Officer

Richard Aranda — Chief Medical Officer

+4.0%1d on move date+3.5% vs SPY3d+7.9%5d+13.9%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more GOSS calls or request research access.

More GOSS calls Browse calls Request research access